Deep Vein Thrombosis (DVT) is the formation of a blood clot (also known as a venous thromboembolism – VTE) within a deep vein, predominantly in the legs. Graymont Medical provides the best equipment to combat against DVT.
Graymont Medical is on the forefront of preventing Deep Vein Thrombosis (DVT). Our products and programs increase patient safety, improve outcomes and reduce costs.
In recent years, venous thromboembolism (VTE) has become a major topic among healthcare professionals. With the trend towards shorter hospital stays, healthcare professionals are now faced with finding appropriate prophylaxis after discharge.
- Over 900,000 Americans are affected by VTE, resulting in 300,000 fatalities each year1,2.
- VTE is the second most common post-operative complication and the third leading cause of post-operative mortality3.
- DVT is the most preventable cause of hospital related deaths3.
Graymont Medical recognizes the need for extending prevention into the home and we are proud to offer mobile compression devices as a solution.
To request additional information from your local representative or to get started, click here or call us at (312) 291-9305
The Cirona® 6300 Portable Deep Vein Thrombosis (DVT) Prevention Therapy System is used to help patients at risk of DVT. At risk patients may include those who experience certain trauma, critical care, general medicine, and general surgery, as well as those who may have undergone neurological, orthopedic, urologic, or obstetric treatments.
Designed as a prophylaxis for Deep Vein Thrombosis, the VenaFlow Elite System combines two proven technologies, rapid inflation and graduated sequential compression, that work to mimic ambulation and accelerate venous velocity.
The VascuTherm2 and 4 offer highly effective DVT prophylaxis through unique and programmable multiple treatment modalities – combining heating/cooling temperature management with vascular compression.
1. Heit J, Cohen A, Anderson FJ. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTA) events in the US. Blood 2005; 106:267A
2. Raskob GE, Silverstein R, Bratzler DW, et al. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 2010 Apr; 38(4Suppl): S502-9. PMID 20331950
3. Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Proactive Guidelines 8th Edition. Chest. 2008; 133(suppl 6): 381S-453S